Eylea Interactions
No drug interactions were found for Eylea (aflibercept ophthalmic). However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Eylea (aflibercept ophthalmic) is in the drug class anti-angiogenic ophthalmic agents. Eylea (aflibercept ophthalmic) is used to treat the following conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Degeneration, Macular Edema, Macular Edema Following Retinal Vein Occlusion , Retinopathy of Prematurity.
Eylea disease interactions
There is 1 disease interaction with Eylea (aflibercept ophthalmic) which include:
Report options
QR code containing a link to this page
More about Eylea (aflibercept ophthalmic)
- Eylea consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (65)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
